The campaign funds research around understanding, diagnosing and treating gastrointestinal cancers, according to a June 27 press release.
Nine research projects across eight organizations were funded this fiscal year, including new cancer vaccines, targeted therapy delivery methods, novel ways to optimize and activate the immune system, clinical trials of colorectal cancer treatments, and liquid biopsy diagnostic techniques.
This is the first year that the research foundation has funded projects outside of its longtime mission partner, the University of Chicago.
The foundation is now extending its CA CURE campaign into fiscal year 2024.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
